Seavey Jonathan G, Wheatley Benjamin M, Pavey Gabriel J, Tomasino Allison M, Hanson Margaret A, Sanders Erin M, Dey Devaveena, Moss Kaitlyn L, Potter Benjamin K, Forsberg Jonathan A, Qureshi Ammar T, Davis Thomas A
Regenerative Medicine Department, Naval Medical Research Center, Silver Spring, Maryland.
Orthopaedics, USU-Walter Reed Department of Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland.
J Orthop Res. 2017 Nov;35(11):2397-2406. doi: 10.1002/jor.23544. Epub 2017 Apr 11.
Heterotopic ossification (HO) is a debilitating sequela of high-energy injuries. It frequently requires surgical excision once symptomatic and there is no practical prophylaxis for combat-injured patients. In this study, we examined the effect of local vancomycin powder on HO formation in a small animal model of blast-related, post-traumatic HO. Male Sprague-Dawley rats were subjected to a polytraumatic extremity injury and amputation with or without methicillin-resistant Staphylococcus aureus infection. Animals were randomized to receive a single local application of vancomycin (20 mg/kg) at the time of injury (POD-0, n = 34) or on postoperative day-3 (POD-3, n = 11). Quantitative volumetric measurement of ectopic bone was calculated at 12-weeks post-injury by micro-CT. Bone marrow and muscle tissues were also collected to determine the bacterial burden. Blood for serum cytokine analysis was collected at baseline and post-injury. Vancomycin treatment on POD-0 suppressed HO formation by 86% and prevented bone marrow and soft tissue infections. We concurrently observed a marked reduction histologically in nonviable tissue, chronic inflammatory cell infiltrates, bone infection, fibrous tissue, and areas of bone necrosis within this same cohort. Delayed treatment was significantly less efficacious. Neither treatment had a marked effect on the production of pro-inflammatory cytokines. Our study demonstrates that local vancomycin treatment at the time of injury significantly reduces HO formation in both the presence and absence of infection, with decreased efficacy if not given early. These findings further support the concept that the therapeutic window for prophylaxis is narrow, highlighting the need to develop early treatment strategies for clinical management. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:2397-2406, 2017.
异位骨化(HO)是高能损伤的一种致残性后遗症。一旦出现症状,通常需要手术切除,而对于战伤患者尚无切实可行的预防措施。在本研究中,我们在爆炸相关的创伤后HO小动物模型中研究了局部应用万古霉素粉末对HO形成的影响。将雄性Sprague-Dawley大鼠造成多发伤肢体损伤并截肢,分为有或无耐甲氧西林金黄色葡萄球菌感染两组。动物被随机分为在受伤时(伤后第0天,n = 34)或术后第3天(伤后第3天,n = 11)单次局部应用万古霉素(20 mg/kg)。在伤后12周通过微型CT对异位骨进行定量体积测量。还收集骨髓和肌肉组织以确定细菌负荷。在基线和伤后采集血液进行血清细胞因子分析。伤后第0天进行万古霉素治疗可使HO形成减少86%,并预防骨髓和软组织感染。我们同时观察到在同一队列中,组织学上非存活组织、慢性炎性细胞浸润、骨感染、纤维组织和骨坏死区域明显减少。延迟治疗效果明显较差。两种治疗对促炎细胞因子的产生均无显著影响。我们的研究表明,受伤时局部应用万古霉素在有或无感染的情况下均能显著减少HO形成,若不早期应用则疗效降低。这些发现进一步支持了预防的治疗窗口较窄这一概念,突出了制定早期治疗策略用于临床管理的必要性。© 2017骨科学研究协会。由Wiley Periodicals, Inc.出版。《矫形外科学研究》35:2397 - 2406, 2017。